FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?
Executive Summary
CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention.
You may also be interested in...
CDER Recruitment Wins Begin Outnumbering Losses
US FDA's drug center has been hiring more employees than it has lost over the last few months and hopes the Office of New Drugs reorganization will help retention.
Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director
Peter Stein, a leader in diabetes drug development programs, joins FDA as a new administration is about to come in; he fills one of 676 CDER vacancies.
FDA's Pazdur To Retain Drug Approval Duties In Oncology Center Of Excellence
Center for Drug Evaluation and Research's long-time director of oncology/hematology products office will continue as signatory on drug reviews even after new Cancer Moonshot-driven structure takes effect.